BIOEX — Bioextrax AB publ Cashflow Statement
0.000.00%
Last trade - 00:00- SEK101.67m
- SEK97.74m
- SEK0.76m
Annual cashflow statement for Bioextrax AB publ, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.5 | -18.7 | -21.6 | -17.5 | -17.8 |
| Depreciation | |||||
| Non-Cash Items | 0.35 | 0 | 0.092 | 0.201 | 0.134 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.71 | 0.586 | -2.66 | -2.6 | -9.47 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.48 | -17.6 | -23.3 | -18.8 | -26 |
| Capital Expenditures | -0.975 | -6.78 | -1.1 | -0.215 | -0.152 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.975 | -6.78 | -1.1 | -0.215 | -0.152 |
| Financing Cash Flow Items | — | -7.67 | -0.511 | -4.01 | -2.63 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 16.4 | 42.9 | 10.3 | 22.9 | 12.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.93 | 18.6 | -14.1 | 3.87 | -13.3 |